Background Streptococcus pneumoniae (pneumococcus) is a major human pathogen. Pneumococci carried in the pharynx are the reservoir for both transmission and infection. There are 90 antigenically distinct serotypes based on the polysaccharide capsule. Anti-capsular antibodies provide type-specific immunity. In 2000, a pneumococcal conjugate vaccine, a vaccine containing capsular antigens from seven serotypes that markedly reduces the incidence of invasive infections in infants, was licensed and is now given to all U.S. infants. Vaccine recipients have reduced carriage of vaccine serotypes but an apparent increase in carriage of other serotypes. Standard methods for growing pneumococci from respiratory specimens have a limited sensitivity and generally detect only a single serotype although carriage of more than one serotype is common. There is a need for more sensitive tests that detect all serotypes present in pharyngeal specimens. The broad, long-term objective of this project is to study the carriage of all serotypes of pneumococci and the effect of vaccines on carriage.
Specific Aims To develop sensitive and specific PCR-based assays to detect DNA from 30 serotypes/serogroups that account for 99% of pneumococci in clinical specimens. To compare the sensitivity and specificity of these assays with standard culture and mouse injection for detection of all serotypes present in clinical pharyngeal specimens. Research Plan For each of 30 serotypes (or serogroups) that collectively comprise 99% of clinical isolates, serotype/serogroup-specific genes & sequences in the capsular polysaccharide biosynthetic cluster will be identified. Using these sequences sensitive PCR-based assays will be developed for each of the 30. The specificity of each assay will be tested using DNA from strains of the 90 serotypes & other bacteria that colonize the pharynx. The sensitivity for detecting all serotypes of pneumococci in respiratory specimens will be compared with standard culture & mouse inoculation. Significance These PCR-based assays will allow more sensitive detection of all serotypes present in respiratory specimens resulting in a more complete understanding of the epidemiology of colonization. They will be used to test the hypothesis that the prevalence of colonization with non-vaccine serotypes is similar in vaccinated and unvaccinated infants. Furthermore, they will be critical for determining the effects of current and future pneumococcal vaccines on serotype-specific carriage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI058200-01A1
Application #
6820108
Study Section
Special Emphasis Panel (ZRG1-SSS-F (02))
Program Officer
Klein, David L
Project Start
2004-05-01
Project End
2007-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
1
Fiscal Year
2004
Total Cost
$371,600
Indirect Cost
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030